213 related articles for article (PubMed ID: 8540088)
1. No beneficial effects, but severe side effects caused by recombinant human tissue plasminogen activator for treatment of hepatic veno-occlusive disease after allogeneic bone marrow transplantation.
Hägglund H; Ringdén O; Ljungman P; Winiarski J; Ericzon B; Tydén G
Transplant Proc; 1995 Dec; 27(6):3535. PubMed ID: 8540088
[No Abstract] [Full Text] [Related]
2. [Treatment of hepatic veno-occlusive disease after bone marrow transplantation with recombinant human tissue plasminogen activator (rh-tPA)].
Yoshimi A; Kato K; Maeda N; Matsuyama T; Kojima S
Rinsho Ketsueki; 2000 Feb; 41(2):103-8. PubMed ID: 10723238
[TBL] [Abstract][Full Text] [Related]
3. Fatal hemorrhage after recombinant tissue plasminogen activator therapy for hepatic veno-occlusive disease complicating autologous BMT.
Otheo de Tejada E; Maldonado MS; Camarero C; Muñoz A
Bone Marrow Transplant; 1994 Jul; 14(1):176-7. PubMed ID: 7951113
[No Abstract] [Full Text] [Related]
4. Recombinant human tissue plasminogen activator for the treatment of severe hepatic veno-occlusive disease in pediatric bone marrow transplant patients.
Leahey AM; Bunin NJ
Bone Marrow Transplant; 1996 Jun; 17(6):1101-4. PubMed ID: 8807121
[TBL] [Abstract][Full Text] [Related]
5. A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantation.
Terra SG; Spitzer TR; Tsunoda SM
Pharmacotherapy; 1997; 17(5):929-37. PubMed ID: 9324182
[TBL] [Abstract][Full Text] [Related]
6. Recombinant tissue plasminogen activator (rTPA) for hepatic veno-occlusive disease after allogeneic BMT in a pediatric patient.
Feldman L; Gabai E; Milovic V; Jaimovich G
Bone Marrow Transplant; 1995 Nov; 16(5):727. PubMed ID: 8547875
[No Abstract] [Full Text] [Related]
7. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia.
Lee JH; Lee KH; Choi SJ; Min YJ; Kim JG; Kim S; Lee JS; Kim SH; Park CJ; Chi HS; Kim WK
Bone Marrow Transplant; 2000 Sep; 26(6):657-62. PubMed ID: 11041568
[TBL] [Abstract][Full Text] [Related]
8. Double treatment of severe hepatic veno-occlusive disease after allogeneic peripheral blood progenitor cell transplantation with recombinant tissue plasminogen activator.
Söhngen D; Bauser U; Boogen C; Aul C; Frieling T; Germing U; Schneider P; Kobbe G; Heyll A
Thromb Haemost; 1997 Oct; 78(4):1299-300. PubMed ID: 9365005
[No Abstract] [Full Text] [Related]
9. Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA).
Baglin TP; Harper P; Marcus RE
Bone Marrow Transplant; 1990 Jun; 5(6):439-41. PubMed ID: 2369685
[TBL] [Abstract][Full Text] [Related]
10. Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment.
Bajwa RP; Cant AJ; Abinun M; Flood TJ; Hodges S; Hale JP; Skinner R
Bone Marrow Transplant; 2003 Apr; 31(7):591-7. PubMed ID: 12692627
[TBL] [Abstract][Full Text] [Related]
11. Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation.
Schriber J; Milk B; Shaw D; Christiansen N; Baer M; Slack J; Tezcan H; Wetzler M; Herzig G
Bone Marrow Transplant; 1999 Dec; 24(12):1311-4. PubMed ID: 10627640
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of veno-occlusive disease with recombinant tissue plasminogen activator in a patient requiring peritoneal dialysis.
Simpson DR; Browett PJ; Doak PB; Palmer SJ
Bone Marrow Transplant; 1994 Oct; 14(4):635-6. PubMed ID: 7858540
[TBL] [Abstract][Full Text] [Related]
13. Management of hepatic veno-occlusive disease (VOD) in pediatric patients: retrospective analysis in 6 AIEOP-BMT (Italian Pediatric Hematology Oncology Association-Bone Marrow Transplantation Group) Centers.
Miniero R; Vassallo E; Soldano S; Nesi F; Vai S; Balduzzi A; Varotto S; Dallorso S; Prete A; Arcese W
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():157-9. PubMed ID: 8932820
[No Abstract] [Full Text] [Related]
14. Successful treatment of an infant with veno-occlusive disease developed after allogeneic bone marrow transplantation by tissue plasminogen activator, heparin and prostaglandin E1.
Higashigawa M; Watanabe M; Nishihara H; Tabata N; Azuma E; Ido M; Ito M; Sakurai M
Leuk Res; 1995 Jul; 19(7):477-80. PubMed ID: 7637394
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations.
Schlitt HJ; Tischler HJ; Ringe B; Raddatz G; Maschek H; Dietrich H; Kuse E; Pichlmayr R; Link H
Bone Marrow Transplant; 1995 Sep; 16(3):473-8. PubMed ID: 8535323
[TBL] [Abstract][Full Text] [Related]
16. [A trial use of prostaglandin E1 for prevention of hepatic veno-occlusive disease after allogeneic bone marrow transplantation].
Morio S; Oh H; Kogure K; Ishii H; Ishii A; Nakaseko C; Ikegami T; Kawano E; Matsuura Y; Nishimura M
Rinsho Ketsueki; 1994 Sep; 35(9):846-52. PubMed ID: 7967053
[TBL] [Abstract][Full Text] [Related]
17. Hepatic veno-occlusive disease with severe capillary leakage after peripheral stem cell transplantation: treatment with recombinant plasminogen activator and C1-esterase inhibitor concentrate.
Heying R; Nürnberger W; Spiekerkötter U; Göbel U
Bone Marrow Transplant; 1998 May; 21(9):947-9. PubMed ID: 9613790
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hepatic veno-occlusive disease with low-dose tissue plasminogen activator: impact on coagulation profile.
Goldberg SL; Shubert J; Rao AK; Redei I; Klumpp TR; Mangan KF
Bone Marrow Transplant; 1996 Sep; 18(3):633-6. PubMed ID: 8879629
[TBL] [Abstract][Full Text] [Related]
19. Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantation.
Abecasis MM; Conceição Silva JP; Ferreira I; Guimarães A; Machado A
Bone Marrow Transplant; 1999 Apr; 23(8):843-6. PubMed ID: 10231151
[TBL] [Abstract][Full Text] [Related]
20. Alteplase for hepatic veno-occlusive disease after bone marrow transplantation.
Ringdén O; Wennberg L; Ericzon BG; Kallman R; Aström M; Duraj F; Söderdahl G; Tydén G; Groth CG
Lancet; 1992 Aug; 340(8818):546-7. PubMed ID: 1354293
[No Abstract] [Full Text] [Related]
[Next] [New Search]
